1. Home
  2. ACMR vs AMRX Comparison

ACMR vs AMRX Comparison

Compare ACMR & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACMR

ACM Research Inc.

HOLD

Current Price

$97.82

Market Cap

4.2B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.16

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACMR
AMRX
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.0B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
ACMR
AMRX
Price
$97.82
$17.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$50.00
$15.60
AVG Volume (30 Days)
1.8M
2.2M
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
0.24
0.19
Revenue
$74,643,000.00
N/A
Revenue This Year
$29.37
$4.48
Revenue Next Year
$23.16
$7.13
P/E Ratio
$488.79
$89.37
Revenue Growth
104.47
N/A
52 Week Low
$23.03
$7.67
52 Week High
$127.19
$17.86

Technical Indicators

Market Signals
Indicator
ACMR
AMRX
Relative Strength Index (RSI) 50.01 74.60
Support Level $35.32 $12.46
Resistance Level N/A N/A
Average True Range (ATR) 9.85 0.55
MACD -0.09 -0.00
Stochastic Oscillator 14.28 61.74

Price Performance

Historical Comparison
ACMR
AMRX

About ACMR ACM Research Inc.

ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: